Objective: To explore the infection rate of HBV of Yao population in Ruyuan and the correction between Hepatitis B virus genotypes and clinical disease spectra. Methods: ELISA was used to detect hepatitis B virus markers of 665 Yao population and 589 Han population. And microboard nucleate molecular hybridization ELISA was used to detect the genotype of 97 cases of different clinical types of HBV infections. Results: HBsAg positive rate of Yao population (20.3%) was higher than Han population (13.4%), and significance difference was found in males (25.81% vs 13.22%, P < 0.05). Among the 97 HBV patients of Yao population, genotype B took up the largest proportion (52.58%, 51/97), followed by genotype C (36.08%, 35/97), and then 7 cases of mixed genotype (4 cases of B/C, 3 cases of C/D). No genotype E or F was detected. Genotype B was higher than genotype C (52.94% vs 25.71%, p < 0.05) in asymptomatic carriers, while genotype C was higher than genotype B (62.85% vs 27.45%, p < 0.05) in mild or moderate chronic hepatitis B. Conclusion: HBsAg positive rate of males in Ruyuan of Yao population was higher than that of Han population. Genotype B was the main type in this area, followed by genotype C.
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Methods: This study included 85 patients with chronic hepatitis B due to genotype D, who received lamivudine 100 mg daily for at least 12 months (10 females, age 32±8 years). 73 (85) 
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Aim: To study was to investigate the genotypic prevalence and clinical significance of HCV, HBV, and/or HDV among chronic hepatitis patients with and without liver cirrhosis and/or HCC in Tajikistan. Methods: Sera were obtained from 124 consecutive cases of chronic liver diseases. Patients in this study were classified into two clinical groups: (i) chronic hepatitis and (ii) liver cirrhosis. Results: Genotypes of HBV, HCV, and HDV were determined by genetic sequencing. The overall prevalence of anti-HCV, HCV core antigen (HCVcAg) and HBsAg was 46% (57/124) and 41.1% (51/124), respectively. Co-infection of HCV/HBV, HBV/HDV, and HCV/HBV/HDV was found in 4.8% (6/124), 11.2% (12/124), and 0.8% (1/124) of cases, respectively. HDV genotype 1 was found in 19.6% (10/51) of HBsAgpositive patients. The HBV/HDV co-infection was relatively high in group 2 compared with group 1 (15% vs. 7.1%). HCV/1b was detected in 84.6% (44/52) of HCV RNA-positive patients, followed by 3a (7.6%), 2a (5.7%), and 2c (1.9%). HBV/D was detected in 94.1% (48/51) of HBsAg-positive patients, followed by HBV/A [5.8% (3/51)]. T1762/A1764 double mutation was associated with liver cirrhosis in HBVinfected patients (P = 0.0004). Conclusion: Among HBV-infected patients, the T1762/A1764 mutation was associated with liver cirrhosis. Objectives: This study aims to evaluate the antioxidative effects of caffeic acid phenethyl ester (CAPE) with various doses, which was given by intraperitoneal injection or oral route, in rats with chronic liver injury induced by carbon tetrachloride (CCl 4 ), alcohol and high-lipid forage. Methods: Ninety-five Sprague-Dawley rats were divided randomly into nine groups as follows: blank control, solvent
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